Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Agios, Alkermes, Alvotech, Anavex, Athira, Belief, Chemomab, Cymabay, Dyne, Genascence, Keros, Maplight, Ocuterra, Recode, Regulus, Salarius, Sciwind, Therapeutic Solutions, Upstream, Ultragenyx, Ventus.